Sigma Healthcare Limited
SIG
Κατάταξη σε μετοχές
#1056
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Τιμή μετοχής
$1.93
Κεφαλαιοποίηση
$22.23B
Αλλαγή (1 ημέρα)
-0.90%
Αλλαγή (1 έτος)
-2.07%
Χώρα
AU
Εμπόριο Sigma Healthcare Limited (SIG)
Κατηγορία
Healthcare
Κέρδη για την Sigma Healthcare Limited (SIG)
Κέρδη τον Jun 2026 TTM: $708.86M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Sigma Healthcare Limited, τα τρέχοντα κέρδη της εταιρείας είναι $708.86M. Το 2024, η εταιρεία παρουσίασε κέρδη $5.66M, αύξηση σε σχέση με των κερδών του 2023 που ήταν $3.85M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Sigma Healthcare Limited από 2001 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $708.86M | 10,096.86% |
| 2025 | $6.95M | 22.78% |
| 2024 | $5.66M | 47.02% |
| 2023 | $3.85M | -165.59% |
| 2022 | $-5.87M | -126.98% |
| 2021 | $21.76M | -306.27% |
| 2020 | $-10.55M | -127.92% |
| 2019 | $37.78M | -40.47% |
| 2018 | $63.46M | 9.21% |
| 2017 | $58.11M | 6.92% |
| 2016 | $54.35M | -7.44% |
| 2015 | $58.71M | -1.86% |
| 2014 | $59.82M | 130.12% |
| 2013 | $26.00M | -65.98% |
| 2012 | $76.42M | -187.31% |
| 2011 | $-87.53M | -67.44% |
| 2010 | $-268.78M | -435.64% |
| 2009 | $80.08M | -18.27% |
| 2008 | $97.98M | -5.93% |
| 2007 | $104.16M | 37.29% |
| 2006 | $75.87M | 249.98% |
| 2004 | $21.68M | 59.62% |
| 2003 | $13.58M | 86.27% |
| 2002 | $7.29M | 86.95% |
| 2001 | $3.90M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $6.46B | 811.04% |
US
|
|
| - | - |
US
|
|
| $2.17B | 206.69% |
US
|
|
| - | - |
US
|
|
| $558.00M | -21.28% |
US
|
